Compatible with all major sequencing platforms, QCI Analyze efficiently converts FASTQ files to VCF files through preconfigured, comprehensive and scalable pipelines controlled by role-based permissions. The software uses powerful, globally recognized algorithms to pinpoint even the most difficult-to-detect variants and fusions.
Significantly reducing secondary analysis processing time from days to minutes, QCI Analyze enables higher test throughput without sacrificing precision or accuracy.
QCI Analyze offers “out-of-box” implementation or can be customized to your assay on any sequencing platform through QIAGEN Clinical Informatics Services.
As next-generation sequencing (NGS) continues to become faster and cheaper, commensurate speeds and costs are required for NGS secondary analysis—the critical step that maps and aligns the sequence reads to a reference genome and identifies the genomic locations exhibiting variations. However, NGS secondary analysis involves sequences of steps, each performed by a software tool, that vary by application and introduce workflow complexities. To improve NGS assay development and routine clinical testing, clinical labs need automated and standardized secondary analysis pipelines.
Join us for a demonstration of QCI Analyze and learn how this NGS secondary analysis solution can help your lab: